Leland F. Damron

Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency

J. Mascola, Reda Rawi, Baoshan Zhang, 2023, mAbs.

Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life

J. Mascola, Chen-Hsiang Shen, Baoshan Zhang, 2022, Scientific Reports.